Braune S, Albus M, Frohler M, Hohn T, SCHEIBE G
Eur Arch Psychiatry Clin Neurosci. 1994; 244(2):86-92.
PMID: 7948059
DOI: 10.1007/BF02193524.
Pimoule C, Briley M, Gay C, Loo H, Sechter D, Zarifian E
Psychopharmacology (Berl). 1983; 79(4):308-12.
PMID: 6407043
DOI: 10.1007/BF00433407.
Kerry R, Scrutton M, Wallis R
Br J Pharmacol. 1984; 81(1):91-102.
PMID: 6322894
PMC: 1986950.
DOI: 10.1111/j.1476-5381.1984.tb10748.x.
Tsukahara T, Taniguchi T, Fujiwara M, Handa H
Naunyn Schmiedebergs Arch Pharmacol. 1983; 324(2):88-93.
PMID: 6316168
DOI: 10.1007/BF00497012.
Maj J, GORKA Z, Melzacka M, Rawlow A, Pilc A
Naunyn Schmiedebergs Arch Pharmacol. 1983; 322(4):256-60.
PMID: 6306487
DOI: 10.1007/BF00508340.
Characteristics of the [3H]-yohimbine binding on rat brain alpha2-adrenoceptors.
Rouot B, Quennedey M, Schwartz J
Naunyn Schmiedebergs Arch Pharmacol. 1982; 321(4):253-9.
PMID: 6300700
DOI: 10.1007/BF00498509.
Binding of yohimbine stereoisomers to alpha-adrenoceptors in rat liver and human platelets.
Ferry N, Goodhardt M, Hanoune J, Sevenet T
Br J Pharmacol. 1983; 78(2):359-64.
PMID: 6299443
PMC: 2044702.
DOI: 10.1111/j.1476-5381.1983.tb09401.x.
The effects of monovalent and divalent cations on the alpha-adrenoceptor of intact human platelets.
Elliott J, Grahame-Smith D
Br J Pharmacol. 1982; 77(2):277-83.
PMID: 6291686
PMC: 2044607.
DOI: 10.1111/j.1476-5381.1982.tb09296.x.
Acute reduction in human platelet alpha 2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines.
Hollister A, FitzGerald G, Nadeau J, Robertson D
J Clin Invest. 1983; 72(4):1498-505.
PMID: 6138365
PMC: 370434.
DOI: 10.1172/JCI111106.
Alpha 2-adrenoceptors in platelets of spontaneously hypertensive rats.
Minuth M, Jakobs K
Naunyn Schmiedebergs Arch Pharmacol. 1983; 322(2):98-103.
PMID: 6135162
DOI: 10.1007/BF00512381.
Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation.
Molinoff P
Drugs. 1984; 28 Suppl 2:1-15.
PMID: 6098436
DOI: 10.2165/00003495-198400282-00002.
Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
Pfeifer M, Ward K, Malpass T, Stratton J, Halter J, Evans M
J Clin Invest. 1984; 74(3):1063-72.
PMID: 6088579
PMC: 425265.
DOI: 10.1172/JCI111473.
Platelet alpha-adrenoceptors--a valid model for brain or vascular adrenoceptors?.
Hamilton C, Reid J
Br J Clin Pharmacol. 1986; 22(6):623-6.
PMID: 3032225
PMC: 1401204.
DOI: 10.1111/j.1365-2125.1986.tb02948.x.
Sympathetic denervation and alpha adrenoceptors in dog cerebral arteries.
Tsukahara T, Taniguchi T, Usui H, Miwa S, Shimohama S, Fujiwara M
Naunyn Schmiedebergs Arch Pharmacol. 1986; 334(4):436-43.
PMID: 3029605
DOI: 10.1007/BF00569383.
Simultaneous measurement of epinephrine-induced platelet aggregation in 14 plasma samples.
Nelson K, Heintz S, Ulrich S, Kirsten R
Eur J Clin Pharmacol. 1986; 30(3):289-94.
PMID: 3015638
DOI: 10.1007/BF00541530.
3H-clonidine and 3H-yohimbine binding to glass fiber filters: implications for studies with platelet membranes.
Piletz J, Andorn A, Halaris A
Psychopharmacology (Berl). 1986; 89(3):370-7.
PMID: 3014594
DOI: 10.1007/BF00174377.
Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.
Schloos J, Wellstein A, Palm D
Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(1):48-59.
PMID: 2888026
DOI: 10.1007/BF00177750.
Rapid and reversible desensitisation of vascular and platelet alpha 2 adrenoceptors.
Hamilton C, Deighton N, Reid J
Naunyn Schmiedebergs Arch Pharmacol. 1987; 335(5):534-40.
PMID: 2886922
DOI: 10.1007/BF00169120.
[3H]-rauwolscine binding to alpha 2-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species.
Neylon C, Summers R
Br J Pharmacol. 1985; 85(2):349-59.
PMID: 2862942
PMC: 1916613.
DOI: 10.1111/j.1476-5381.1985.tb08868.x.
Alterations in platelet alpha 2-adrenoceptors by aspirin.
Mehta J, Mehta P, Lawson D
Agents Actions. 1988; 24(1-2):196-203.
PMID: 2841831
DOI: 10.1007/BF01968101.
